Yet despite this significant limitation, taken together, the data demonstrate that human immune lineages, including myeloid cells, can develop from MBP-CD34 cells from adult HNSCC cancer patients and allow for engraftment and chimerism of immunodeficient mice with major immune compartments represented. Here, CD34 is linked to head and neck squamous cell carcinoma.